Garcia-Prats AJ - Search Results

1

Children exposed to multidrug-resistant tuberculosis at a home-based day care centre: a contact investigation.

Garcia-Prats AJ, Zimri K, Mramba Z, Schaaf HS, Hesseling AC. Garcia-Prats AJ, et al. Int J Tuberc Lung Dis. 2014 Nov;18(11):1292-8. doi: 10.5588/ijtld.13.0872. Int J Tuberc Lung Dis. 2014. PMID: 25299860

2

Linezolid for the treatment of drug-resistant tuberculosis in children: a review and recommendations.

Garcia-Prats AJ, Rose PC, Hesseling AC, Schaaf HS. Garcia-Prats AJ, et al. Tuberculosis (Edinb). 2014 Mar;94(2):93-104. doi: 10.1016/j.tube.2013.10.003. Epub 2013 Oct 27. Tuberculosis (Edinb). 2014. PMID: 24388605 Review.

3

Pharmacokinetics of ofloxacin and levofloxacin for prevention and treatment of multidrug-resistant tuberculosis in children.

Thee S, Garcia-Prats AJ, McIlleron HM, Wiesner L, Castel S, Norman J, Draper HR, van der Merwe PL, Hesseling AC, Schaaf HS. Thee S, et al. Antimicrob Agents Chemother. 2014 May;58(5):2948-51. doi: 10.1128/AAC.02755-13. Epub 2014 Feb 18. Antimicrob Agents Chemother. 2014. PMID: 24550337 Free PMC article.

4

Managing multidrug-resistant tuberculosis in children: review of recent developments.

Schaaf HS, Garcia-Prats AJ, Hesseling AC, Seddon JA. Schaaf HS, et al. Curr Opin Infect Dis. 2014 Jun;27(3):211-9. doi: 10.1097/QCO.0000000000000062. Curr Opin Infect Dis. 2014. PMID: 24751893 Review.

5

Acquired drug resistance during inadequate therapy in a young child with tuberculosis.

Garcia-Prats AJ, Willemse M, Seifart HI, Jordaan AM, Werely CJ, Donald PR, Schaaf HS. Garcia-Prats AJ, et al. Pediatr Infect Dis J. 2014 Aug;33(8):883-5. doi: 10.1097/INF.0000000000000336. Pediatr Infect Dis J. 2014. PMID: 25222312

6

Toxicity and tolerability of fluoroquinolone-based preventive therapy for childhood contacts of multidrug-resistant tuberculosis.

Seddon JA, Garcia-Prats AJ, Kampmann B, Schaaf HS, Hesseling AC. Seddon JA, et al. Pediatr Infect Dis J. 2014 Oct;33(10):1098-9. doi: 10.1097/INF.0000000000000369. Pediatr Infect Dis J. 2014. PMID: 25361192 No abstract available.

7

In reply: Acquired drug-resistance because of pharmacokinetic variability in a young child with tuberculosis.

Garcia-Prats AJ, Donald PR, Schaaf HS. Garcia-Prats AJ, et al. Pediatr Infect Dis J. 2014 Nov;33(11):1205-6. doi: 10.1097/INF.0000000000000404. Pediatr Infect Dis J. 2014. PMID: 25361415 No abstract available.

8

Pharmacokinetics and safety of moxifloxacin in children with multidrug-resistant tuberculosis.

Thee S, Garcia-Prats AJ, Draper HR, McIlleron HM, Wiesner L, Castel S, Schaaf HS, Hesseling AC. Thee S, et al. Clin Infect Dis. 2015 Feb 15;60(4):549-56. doi: 10.1093/cid/ciu868. Epub 2014 Oct 30. Clin Infect Dis. 2015. PMID: 25362206 Free PMC article.

9

Fluoroquinolones for the treatment of tuberculosis in children.

Thee S, Garcia-Prats AJ, Donald PR, Hesseling AC, Schaaf HS. Thee S, et al. Tuberculosis (Edinb). 2015 May;95(3):229-45. doi: 10.1016/j.tube.2015.02.037. Epub 2015 Feb 14. Tuberculosis (Edinb). 2015. PMID: 25797610 Review.

10

Antituberculosis drugs in children.

Schaaf HS, Garcia-Prats AJ, Donald PR. Schaaf HS, et al. Clin Pharmacol Ther. 2015 Sep;98(3):252-65. doi: 10.1002/cpt.164. Epub 2015 Jul 14. Clin Pharmacol Ther. 2015. PMID: 26095192 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters